Oncoscope is now available on iPad

Request free access to get started

The Market Access Podcast: Will AI and Living Reviews Define the Next Era of Health Care Market Access?

Will AI and Living Reviews Define the Next Era of Health Care Market Access?

Oncoscope-AI Founder & CEO Anna Forsythe was recently on the Market Access Podcast with Dr. Stefan Walzer to discuss how Living Systematic Literature Reviews (Living SLRs) are redefining evidence generation in oncology and beyond – highlighting the power of real-time updates, advanced automation, and the essential role of human insight.

Traditional SLRs are static snapshots, while Living SLRs are real-time, dynamic, and AI-powered—delivering continuously updated insights crucial for life-or-death decisions and payer evaluations. Join this discussion as they explore the myth of AI chatbots as true decision support tools, the need for actionable data over summaries, and the future of evidence synthesis, clinical decision-making, and smarter market access.

Listen on Spotify:

Listen on YouTube:

Listen on PocketCasts:

Recent posts

As medicine becomes more precise, evidence must become more connected
Oncology Needs Living Evidence, Not More AI Summaries
Why AI’s Biggest Blind Spot In Pharma Isn’t Technical by Anna Forsythe for Forbes
Why AI’s Biggest Blind Spot In Pharma Isn’t Technical

Login

Edge

For physicians seeking patient-level treatment guidance and KOLs shaping the next generation of standards of care.

Enterprise

For pharmaceutical innovators to support strategic decisions and regulatory & reimbursement submissions.